Drug Discovery 시장 규모는 향후 몇 년동안 빠르게 성장할 것으로 예상되며, 2029년까지 15.3%의 성장률로 2,217억 1,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 정밀의료의 채택, 희귀질환에 대한 집중, 개인맞춤형 치료의 확대에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 공동연구 Drug Discovery 모델, 희귀질환 및 희귀질환 치료제에 대한 관심, 멀티오믹스 데이터 통합, 오가노이드 및 3D 세포배양 모델의 급속한 채택, 가상 스크리닝의 발전 등이 있습니다.
헬스케어 지출 증가는 향후 몇 년동안 Drug Discovery 시장을 견인할 것으로 예상됩니다. 세계 각국은 GDP의 상당 부분을 병원 의료, 의사 및 임상 서비스, 각종 전문 서비스, 치과 서비스, 기타 의료 서비스, 주택 및 퍼스널케어, 재택치료, 요양원, 요양원, 노인 요양원, 은퇴자 커뮤니티, 처방약 등에 지출하고 있습니다. Drug Discovery은 질병을 치료하고 수명을 연장하는 데 필수적이기 때문에 보건 지출의 매우 중요한 요소입니다. 새로운 질병에 대응하기 위한 신약에 대한 수요가 증가하고 있습니다. 예를 들어, 2024년 10월 미국 연방정부 기관인 메디케어 메디케이드 서비스 센터는 2022년 국민 의료비가 4.1% 증가한 4조 5,000억 달러, 1인당 1만 3,493달러로 2023년부터 2032년까지 국민 의료비가 평균 5.6% 증가할 것으로 예상했습니다. 성장률(5.6%)은 GDP 평균 성장률(4.3%)을 상회할 것으로 예상되며, 그 결과 GDP 대비 의료비 비중은 2022년 17.3%에서 2032년 19.7%로 증가할 것으로 전망됩니다. 이처럼 의료비 지출 증가가 Drug Discovery 시장의 성장을 견인하고 있습니다.
Drug Discovery 시장은 제약 및 생명공학 분야의 연구개발(R&:D) 지출 증가로 인해 성장할 수 있는 여건이 조성되어 있습니다. 제약 및 생명공학 분야의 연구개발비에는 신제품 및 신기술의 발견과 개발에 중점을 둔 연구개발 활동을 위한 자금 배분이 포함됩니다. 이러한 연구개발 활동에 대한 자금 투입은 질병 메커니즘에 대한 이해를 높이고, 전임상시험을 수행하며, 임상시험을 거쳐 최종적으로 신약 및 치료법 개발에 기여하기 위해 필수적인 요소입니다. 일례로 영국 정부는 2022년 연구개발에 대한 지출을 대폭 늘려 2024/25년까지 연간 200억 파운드(254억 3,000만 파운드, 한화 약 6,600억 원)에 달하는 53억 6,000만 파운드(한화 약 6,600억 원)를 추가할 것이라고 발표했습니다. 이번 자금 투입은 2027년까지 모든 분야를 포함한 총 R&D 지출을 GDP의 2.4%로 늘리겠다는 목표를 달성하기 위한 정부 전략의 일환입니다. 제약 및 바이오테크놀러지 분야의 R&D 지출이 크게 증가한다는 것은 신약 개발에 대한 업계의 노력을 강조하고, 전체 신약 개발 시장의 성장을 가속할 수 있는 계기가 될 것입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 Drug Discovery PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
- 최종 이용 산업 분석
- 세계의 Drug Discovery 시장 : 성장률 분석
- 세계의 Drug Discovery 시장 실적 : 규모와 성장, 2019-2024
- 세계의 Drug Discovery 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 Drug Discovery TAM(Total Addressable Market)
제6장 시장 세분화
- 세계의 Drug Discovery 시장 : 약제 유형별 :, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 소분자
- 거대 분자
- 세계의 Drug Discovery 시장 : 프로세스별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 타겟 선택
- 타겟 검증
- Hit-To-Lead Identification
- 리드 최적화
- 후보자 검증
- 세계의 Drug Discovery 시장 : 기술별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- High Throughput Screening
- 분광법
- Combinatorial Chemistry
- 바이오칩
- 약물유전체학 및 약리유전학
- 바이오인포매틱스
- 대사체학
- 나노테크놀러지
- 기타 테크놀러지
- 세계의 Drug Discovery 시장 : 치료 영역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 종양학
- 신경학
- 감염증 및 면역계 질환
- 소화기 질환
- 심혈관 질환
- 당뇨병
- 호흡기 질환
- 기타 치료 영역
- 세계의 Drug Discovery 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 제약회사
- CRO
- 기타 최종사용자
- 세계의 Drug Discovery 시장 : 소분자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 합성 소분자
- 천연 소분자
- 표적 소분자
- 세계의 Drug Discovery 시장 : 거대 분자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 단클론항체
- 단백질 및 펩티드
- 핵산 기반 치료법
제7장 지역별/국가별 분석
- 세계의 Drug Discovery 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 Drug Discovery 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- Drug Discovery 시장 : 경쟁 구도
- Drug Discovery 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
- Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- WuXi AppTec Group Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- GlaxoSmithKline plc
- Eli Lilly and Company
- Laboratory Corporation of America Holdings
- Evotec SE
- Eurofins Scientific SE
- Agilent Technologies Inc.
- Sanofi S.A.
- Charles River Laboratories International Inc.
- Pharmaron Ltd.
- Viva Biotech Ltd.
- Albany Molecular Research Inc.
- Schrodinger Inc.
- BioDuro Ltd.
- Aptuit LLC
- Selvita S.A.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- Drug Discovery 시장(2029년) : 새로운 기회를 제공하는 국가
- Drug Discovery 시장(2029년) : 새로운 기회를 제공하는 부문
- Drug Discovery 시장(2029년) : 성장 전략
제36장 부록
LSH
Drug discovery is the systematic process of identifying biologically active compounds with therapeutic potential. The journey from ideation to development and approval aims to discover new clinical drugs for treating various diseases, whether they are new, existing, or previously incurable.
The drug discovery market involves two main types of drugs include small molecule and large molecule. Small molecules are utilized to identify compounds with suitable properties for development, referring to low molecular weight drugs that can efficiently penetrate cells. The drug discovery process includes target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. Various technologies contribute to drug discovery, such as high throughput screening, spectroscopy, combinatorial chemistry, biochips, pharmacogenomics, pharmacogenetics, bioinformatics, metabolomics, nanotechnology, and others. Drug discovery finds applications in therapeutic areas such as oncology, neurology, infectious and immune system diseases, digestive system diseases, cardiovascular diseases, diabetes, respiratory diseases, and more. Pharmaceutical companies, Contract Research Organizations (CROs), and other end-users engage in drug discovery.
The drug discovery market research report is one of a series of new reports from The Business Research Company that provides drug discovery market statistics, including drug discovery industry global market size, regional shares, competitors with a drug discovery market share, detailed drug discovery market segments, market trends and opportunities, and any further data you may need to thrive in the drug discovery industry. This drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The drug discovery market size has grown rapidly in recent years. It will grow from $110.26 billion in 2024 to $125.23 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to advancements in genomics and proteomics, expanding prevalence of chronic diseases, emergence of biopharmaceuticals.
The drug discovery market size is expected to see rapid growth in the next few years. It will grow to $221.71 billion in 2029 at a compound annual growth rate (CAGR) of 15.3%. The growth in the forecast period can be attributed to precision medicine adoption, focus on rare diseases, expansion of personalized therapies. Major trends in the forecast period include collaborative drug discovery models, focus on rare diseases and orphan drugs, integration of multi-omics data, rapid adoption of organoids and 3D cell culture models, advancements in virtual screening.
The increase in healthcare spending is expected to boost the drug discovery market in the coming years. Countries worldwide are allocating a significant portion of their GDP to healthcare expenses, which encompass hospital care, physician and clinical services, various professional services, dental services, other health services, residential and personal care, home health care, nursing care facilities, continuing care retirement communities, prescription drugs, and more. Drug discovery is a crucial component of health expenditures, as it is essential for treating diseases and extending life. The demand for new medications to address emerging diseases is growing. For example, in October 2024, the Centers for Medicare and Medicaid Services, a US-based federal agency, reported that national health expenditure increased by 4.1% to $4.5 trillion in 2022, or $13,493 per person. From 2023 to 2032, the average growth rate of national health expenditure (5.6%) is projected to exceed that of average GDP growth (4.3%), resulting in an increase in the health spending share of GDP from 17.3% in 2022 to 19.7% in 2032. Thus, the rise in healthcare spending is driving the growth of the drug discovery market.
The drug discovery market is poised for growth, driven by the increasing research and development (R&D) expenditure in the pharma-biotech sector. R&D expenditure in the pharma-biotech sector involves allocating funds for research and development activities, focusing on the discovery and development of new pharmaceutical products and technologies. This financial commitment to R&D activities is essential for advancing the understanding of disease mechanisms, conducting pre-clinical testing, and progressing through clinical trials, ultimately contributing to the development of new medicines and treatments. As an illustration, in 2022, the UK government announced a significant increase in spending on R&D, allocating an additional £5 (6.36) billion to reach £20 (25.43) billion per year by 2024/25. This funding injection is part of the government's strategy to achieve a target of total R&D spending, encompassing all sectors, reaching 2.4% of GDP by 2027. The substantial growth in R&D expenditure in the pharma-biotech sector underscores the industry's commitment to advancing drug discovery, thus propelling the overall growth of the drug discovery market.
Technological advancements play a crucial role in shaping the landscape of the drug discovery market. Companies within this domain are actively incorporating various cutting-edge technologies, including Artificial Intelligence (AI), imaging technology, and others, to streamline and expedite the drug discovery process. This proactive integration of technology aims to reduce the time required for drug discovery, fostering innovation and efficiency in the industry. Imaging technology is a notable aspect of these advancements, enabling the visualization, characterization, and quantification of non-invasive biological activities occurring within organisms in response to medications. These methods, utilizing either probes or the tissue itself, are instrumental in comprehending diseases and identifying novel treatments. As an illustrative example, in May 2023, Google Cloud introduced two AI-powered tools in the drug discovery realm: the Target and Lead Identification Suite and the Multiomics Suite. These tools are designed to empower biotech and pharmaceutical companies by expediting drug discovery and precision medicine efforts. The Target and Lead Identification Suite aids in deciphering the function of amino acids and proteins, while the Multiomics Suite accelerates the discovery and interpretation of genomic data, facilitating the design of precision treatments. This commitment to leveraging advanced technologies exemplifies the industry's dedication to enhancing the drug discovery process through innovative tools and approaches.
Major players in the drug discovery market are actively engaged in creating innovative solutions, such as drug discovery accelerators, to advance the development of sophisticated drug models. Drug discovery accelerators represent various entities, initiatives, or programs meticulously crafted to expedite the intricate process of discovering and developing novel pharmaceutical compounds. An exemplary instance of this commitment to innovation is evident in the collaboration between Novo Nordisk and Evotec. In September 2023, they jointly introduced LAB eN2, a translational drug discovery accelerator. LAB eN2 is specifically crafted to support preclinical research originating from academic institutions, with the ultimate goal of propelling the development of groundbreaking therapeutics. The collaboration's primary focus is to hasten the translation of academic concepts into tangible therapeutic product candidates, particularly within the realms of cardiometabolic disorders, rare blood disorders, and endocrine disorders.
In July 2024, Iktos, a pharmaceutical and biotech company based in France, acquired Synsight for an undisclosed amount. This acquisition seeks to improve Iktos's current platform by incorporating Synsight's advanced technologies, especially its MT Bench system for high-performance screening of biological interactions. Synsight is also a biotechnology company located in France.
Major companies operating in the drug discovery market include Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrodinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.
North America was the largest region in the drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The drug discovery market includes revenues earned by entities by high throughput screening, spectroscopy, combinatorial chemistry, biochips, pharmacogenomics and pharmacogenetics, bioinformatics, metabolomics, and nanotechnology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Drug Discovery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug discovery market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Drug Type: Small Molecule; Large Molecule
- 2) By Process: Target Selection; Target Validation; Hit-To-Lead Identification; Lead Optimization; Candidate Validation
- 3) By Technology: High Throughput Screening; Spectroscopy; Combinatorial Chemistry; Biochips; Pharmacogenomics And Pharmacogenetics; Bioinformatics; Metabolomics; Nanotechnology; Other Technologies
- 4) By Therapeutic Area: Oncology; Neurology; Infectious And Immune System Diseases; Digestive System Diseases; Cardiovascular Diseases; Diabetes; Respiratory Disease; Other Therapeutic Areas
- 5) By End User: Pharmaceutical Companies; CROs; Other End-Users
- Subsegments:
- 1) By Small Molecule: Synthetic Small Molecules; Natural Small Molecules; Targeted Small Molecule Drugs
- 2) By Large Molecule: Monoclonal Antibodies; Proteins And Peptides; Nucleic Acid-Based Therapies
- Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Novartis International AG; Thermo Fisher Scientific Inc.; WuXi AppTec Group
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Drug Discovery Market Characteristics
3. Drug Discovery Market Trends And Strategies
4. Drug Discovery Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Drug Discovery Growth Analysis And Strategic Analysis Framework
- 5.1. Global Drug Discovery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Drug Discovery Market Growth Rate Analysis
- 5.4. Global Drug Discovery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Drug Discovery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Drug Discovery Total Addressable Market (TAM)
6. Drug Discovery Market Segmentation
- 6.1. Global Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Small Molecule
- Large Molecule
- 6.2. Global Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Target Selection
- Target Validation
- Hit-To-Lead Identification
- Lead Optimization
- Candidate Validation
- 6.3. Global Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- High Throughput Screening
- Spectroscopy
- Combinatorial Chemistry
- Biochips
- Pharmacogenomics And Pharmacogenetics
- Bioinformatics
- Metabolomics
- Nanotechnology
- Other Technologies
- 6.4. Global Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oncology
- Neurology
- Infectious And Immune System Diseases
- Digestive System Diseases
- Cardiovascular Diseases
- Diabetes
- Respiratory Disease
- Other Therapeutic Areas
- 6.5. Global Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pharmaceutical Companies
- CROs
- Other End-Users
- 6.6. Global Drug Discovery Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Synthetic Small Molecules
- Natural Small Molecules
- Targeted Small Molecule Drugs
- 6.7. Global Drug Discovery Market, Sub-Segmentation Of Large Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Monoclonal Antibodies
- Proteins And Peptides
- Nucleic Acid-Based Therapies
7. Drug Discovery Market Regional And Country Analysis
- 7.1. Global Drug Discovery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Drug Discovery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Drug Discovery Market
- 8.1. Asia-Pacific Drug Discovery Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Drug Discovery Market
- 9.1. China Drug Discovery Market Overview
- 9.2. China Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Drug Discovery Market
- 10.1. India Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Drug Discovery Market
- 11.1. Japan Drug Discovery Market Overview
- 11.2. Japan Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Drug Discovery Market
- 12.1. Australia Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Drug Discovery Market
- 13.1. Indonesia Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Drug Discovery Market
- 14.1. South Korea Drug Discovery Market Overview
- 14.2. South Korea Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Drug Discovery Market
- 15.1. Western Europe Drug Discovery Market Overview
- 15.2. Western Europe Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Drug Discovery Market
- 16.1. UK Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Drug Discovery Market
- 17.1. Germany Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Drug Discovery Market
- 18.1. France Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Drug Discovery Market
- 19.1. Italy Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Drug Discovery Market
- 20.1. Spain Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Drug Discovery Market
- 21.1. Eastern Europe Drug Discovery Market Overview
- 21.2. Eastern Europe Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Drug Discovery Market
- 22.1. Russia Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Drug Discovery Market
- 23.1. North America Drug Discovery Market Overview
- 23.2. North America Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Drug Discovery Market
- 24.1. USA Drug Discovery Market Overview
- 24.2. USA Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Drug Discovery Market
- 25.1. Canada Drug Discovery Market Overview
- 25.2. Canada Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Drug Discovery Market
- 26.1. South America Drug Discovery Market Overview
- 26.2. South America Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Drug Discovery Market
- 27.1. Brazil Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Drug Discovery Market
- 28.1. Middle East Drug Discovery Market Overview
- 28.2. Middle East Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Drug Discovery Market
- 29.1. Africa Drug Discovery Market Overview
- 29.2. Africa Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Drug Discovery Market Competitive Landscape And Company Profiles
- 30.1. Drug Discovery Market Competitive Landscape
- 30.2. Drug Discovery Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. WuXi AppTec Group Overview, Products and Services, Strategy and Financial Analysis
31. Drug Discovery Market Other Major And Innovative Companies
- 31.1. GlaxoSmithKline plc
- 31.2. Eli Lilly and Company
- 31.3. Laboratory Corporation of America Holdings
- 31.4. Evotec SE
- 31.5. Eurofins Scientific SE
- 31.6. Agilent Technologies Inc.
- 31.7. Sanofi S.A.
- 31.8. Charles River Laboratories International Inc.
- 31.9. Pharmaron Ltd.
- 31.10. Viva Biotech Ltd.
- 31.11. Albany Molecular Research Inc.
- 31.12. Schrodinger Inc.
- 31.13. BioDuro Ltd.
- 31.14. Aptuit LLC
- 31.15. Selvita S.A.
32. Global Drug Discovery Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Drug Discovery Market
34. Recent Developments In The Drug Discovery Market
35. Drug Discovery Market High Potential Countries, Segments and Strategies
- 35.1 Drug Discovery Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Drug Discovery Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Drug Discovery Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
